Global Medical Device Cybersecurity Market Size (2026-2030)
In 2025, the Medical Device Cybersecurity Market was valued at approximately USD 7.42 Billion. It is projected to grow at a CAGR of around 12% during the forecast period of 2026–2030, reaching an estimated USD 13.08 Billion by 2030.
The Global Medical Device Cybersecurity Market is the commercial market of technologies and services associated with the cybersecurity of connected medical devices, related networks, and the clinical data ecosystems that are related to these technologies. This includes technologies to protect monitoring devices, imaging devices, infusion pumps, wearables, implantables, and more connected care systems. The market usually includes software protections, hardware security, managed services, threat and vulnerability monitoring, and secure deployment. It excludes enterprise cybersecurity investments not specific to medical devices, consumer electronics, or major IT projects that don't directly protect devices.
The market has changed significantly in recent years as health systems rapidly increased digital activities, outpacing many security initiatives. Healthcare organizations now use disparate fleets of older and new devices, which they may manage across multiple facilities and remote locations. Meanwhile, ransomware attacks, software bugs, and new procurement assessment criteria have raised cybersecurity from a technical to an operational concern. And vendors are increasingly being asked to design and build security into products, collaborate on patching processes, and provide lifecycle accountability when customers evaluate products.
This market affects more than just product choice for decision-makers. It's impacting availability, continuity of patient safety, insurance risk, regulatory compliance, and investment. Purchasers now look for solutions that can scale and work with existing workflows, rather than add to complexity. Suppliers with service and update strategies are being sought. With more use of connected devices, if organizations don't invest now, they could face increased cost and time to resolve issues, lengthier procurement times, and unnecessary disruption.

Key Market Insights
- A 59% increase in vulnerabilities drove hospital adoption of continuous monitoring.
- 993 vulnerabilities in devices boosted 2024 patching worldwide.
- 160 exploited vulnerabilities sped up 2024 network segmentation investments.
- $1.94B in losses from outages focused cybersecurity spending by providers.
- 966 products assessed identified the need for wide lifecycle security in 2024.
- 117 vendors evaluated gained consumer focus on vendor transparency.
- 2024 failures highlighted single points of failure, driving hybrid deployments.
- 2024 ransomware attacks boosted managed services security demand.
- 2024 hospital attacks sped endpoint security for clinical devices.
- Asia Pacific initiatives boosted 2024 connected-device security needs.
- Monitoring of cloud deployments grew with 2024 telehealth.
- 2024 cost-driven software-first solutions over hardware upgrades.

Research Methodology
Scope & definitions
- Covers revenues from cybersecurity hardware, software, and services used to protect connected medical devices, hospital device networks, and device data environments.
- Excludes general IT security not attributable to medical-device use cases, unrelated consumer cybersecurity, and non-commercial academic pilots.
- Geography: global with regional/country splits; timeframe includes historical review, base year, and forecast period stated in-report.
- Segmentation follows fixed rules by component, security type, deployment mode, device type, and end user; data dictionary and no-double-counting controls applied throughout.
Evidence collection (primary + secondary)
- Primary research across OEMs, cybersecurity vendors, hospitals, distributors, integrators, regulators, and industry experts; interviews validate pricing, demand, adoption, and risks.
- Secondary sources include annual reports, investor filings, product documentation, procurement releases, clinical IT publications, and verifiable sources such as FDA, U.S. Cybersecurity and Infrastructure Security Agency (CISA), European Commission/MDR guidance, ISO, IEC, HIMSS, and relevant regulators/standards bodies/industry associations specific to Global Medical Device Cybersecurity Market (named in-report).
- Key claims in the report are supported with source-linked evidence.
Triangulation & validation
- Market size estimated using bottom-up vendor revenue aggregation and top-down healthcare cybersecurity allocation models.
- Results reconciled to company financial disclosures where applicable.
- Conflicting-source resolution, outlier testing, and expert revalidation minimize bias.
Presentation & auditability
- Tables/charts use consistent units, assumptions, and rounding protocols.
- Every major estimate retains calculation trails, cited inputs, and version-controlled evidence logs for auditability.

Global Medical Device Cybersecurity Market Drivers
Growing connected care drives the need for security.
Hospitals are increasing their use of connected devices for monitoring, imaging, therapy, and remote care. Data sharing among these assets can be disrupted by security vulnerabilities, disrupting workflows and treatment. Now, enterprises understand that modernization without security causes workflow disruptions and tarnishes reputation.
Hospital automation initiatives are increasing protection demands.
Hospitals are upgrading workflows with smart asset management, automated clinical diagnostic systems, digital nursing workflows, and command centers. These improvements require seamless interoperability of devices, apps, and the cloud. Increasing automation means cyber attacks can disrupt scheduling and inventory management, affecting patient flow.
Security is designed into products.
Device makers are creating products for software upgrades, remote diagnostics, and data-based performance. And this shift creates a need for cybersecurity during the design, implementation, and aftermarket phases. Customers now require secure designs, fast fixes, and communication of vulnerability response plans before making purchases. In turn, manufacturers are building secure coding, testing, and monitoring skills into their software development.
Global Medical Device Cybersecurity Market Restraints
Older equipment, diverse hospital IT platforms, and budget constraints are hampering market adoption. Clinics are challenged to upgrade equipment without downtime, while vendors must redesign and upgrade products and meet higher security standards. It's not easy to integrate across platforms.
Global Medical Device Cybersecurity Market Opportunities
Growth in the deployment of connected care systems offers opportunities to vendors offering ease of protection for diverse device fleets. Managed security, incident response, and secure upgrade services are in growing demand. Growth in remote care also drives gains in mobile device and cloud security.
How this market works end-to-end
- Risk Mapping
Buyers identify connected assets such as implantables, wearables, monitors, and stationary devices.
- Exposure Review
Teams assess outdated software, open ports, weak credentials, unsupported firmware, and network access paths.
- Control Selection
They compare network security, endpoint security, application security, and cloud security options.
- Deployment Choice
They choose on-premise, cloud-based, or hybrid models based on policy, latency, and IT maturity.
- Vendor Screening
Hospitals and manufacturers review integration depth, support models, and update processes.
- Pilot Testing
Solutions are tested on limited device groups to avoid care disruption.
- Rollout Planning
Coverage expands by site, department, or device type with downtime controls.
- Continuous Monitoring
Alerts, patch cycles, and incident response become ongoing operating tasks.
- Audit Readiness
Evidence is maintained for internal governance, tenders, insurers, and regulators.
Why this market matters now
The pressure has changed. In the past, buyers could treat medical device cybersecurity as a side project. Now it affects uptime, procurement outcomes, insurance posture, and trust.
Connected care has expanded faster than many security programs. Hospitals run mixed fleets of new and old devices. Some assets can be patched quickly. Others cannot. That creates uneven risk.
Capital is tighter in many systems, so every spend must show operational value. Buyers want fewer tools, faster deployment, and measurable reduction in downtime exposure.
Manufacturers also face tougher customer questions. Large buyers increasingly ask how products are secured across their lifecycle, not just at launch.
In volatile conditions, the best decisions balance resilience, compliance, and cost discipline.
What matters most when evaluating claims in this market
|
Claim type
|
What good proof looks like
|
What often goes wrong
|
|
Market size
|
Clear boundary of device-specific revenue
|
Includes all healthcare cybersecurity spend
|
|
Growth outlook
|
Segment and region logic explained
|
One global rate applied everywhere
|
|
Vendor strength
|
Real deployments and retention evidence
|
Marketing logos without depth
|
|
Product value
|
Lower downtime, faster response metrics
|
Feature lists with no outcomes
|
|
Compliance readiness
|
Documented processes and update trails
|
Generic claims of being compliant
|
|
ROI case
|
Labor savings plus risk reduction
|
Only soft benefits counted
|
The decision lens
- Define Boundary
Separate device-specific spend from general IT security budgets.
- Rank Critical Assets
Prioritize devices tied to care continuity and revenue impact.
- Compare Architectures
Stress-test on-premise, cloud-based, and hybrid models for your environment.
- Verify Operations
Check patch workflows, alert fatigue risk, support hours, and integrations.
- Test Concentration
Review supplier dependence, contract lock-in, and single-point failure risks.
- Price Full Cost
Include deployment effort, training, maintenance, and response services.
- Time The Move
Act faster if insurance pressure, recent incidents, audits, or expansion plans are near.
The contrarian view
Many market claims are inflated because they mix enterprise security with device security. That distorts demand signals.
A low tool price can hide high integration cost. Buyers often under-budget engineering time and clinical coordination.
More alerts do not equal more safety. Poor signal quality can overload teams and delay response.
One-size global forecasts miss local reality. Regulation, hospital digitization, installed base age, and budget cycles vary widely.
Large installed fleets are not always the best opportunity. Some older environments are hardest to monetize because upgrade paths are slow.
Practical implications by stakeholder
Hospitals & Healthcare Providers
- Shift buying criteria from features to uptime protection and workflow fit.
- Prioritize high-risk departments first.
- Link cyber spend to continuity planning.
Medical Device Manufacturers
- Build secure-by-design evidence into sales cycles.
- Improve patch and vulnerability response discipline.
- Use cybersecurity as a tender differentiator.
Ambulatory Surgical Centers
- Favor simpler managed models with lean IT burden.
- Focus on connected anesthesia, imaging, and monitoring assets.
Diagnostic Laboratories
- Protect analyzers and connected data flows.
- Reduce outage risk that delays turnaround times.
Investors & Strategy Teams
- Watch services mix, renewal quality, and integration moat.
- Avoid growth stories based only on broad market buzz.
MEDICAL DEVICE CYBERSECURITY MARKET REPORT COVERAGE:
|
REPORT METRIC
|
DETAILS
|
|
Market Size Available
|
2025 - 2030
|
|
Base Year
|
2025
|
|
Forecast Period
|
2026 - 2030
|
|
CAGR
|
12%
|
|
Segments Covered
|
By component, end user, security type, deployment mode, device type, and Region
|
|
Various Analyses Covered
|
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
|
|
Regional Scope
|
North America, Europe, APAC, Latin America, Middle East & Africa
|
|
Key Companies Profiled
|
Palo Alto Networks, Inc., Cisco Systems, Inc., Fortinet, Inc., Check Point Software Technologies Ltd., Trend Micro Incorporated, CrowdStrike Holdings, Inc., Microsoft Corporation, IBM Corporation, MedCrypt, Inc., Claroty Ltd., Cynerio Ltd., Nozomi Networks Inc., Siemens Healthineers AG, GE HealthCare Technologies Inc., and Koninklijke Philips N.V |
Global Medical Device Cybersecurity Market Segmentation
Global Medical Device Cybersecurity Market – By Component
- Introduction/Key Findings
- Hardware
- Software
- Services
- Others
- Y-O-Y Growth Trend & Opportunity Analysis
Software is the leading 42.3% in 2026, with a scalable need for monitoring encryption and patching of connected devices in hospitals globally today, and clinics' secure operations daily now here.
But services are the fastest-growing segment, 12.8% CAGR to 2030, as hospitals outsource threat detection, response, and compliance management. Software remains vital with recurring fees and upgrades globally due to a skills shortage today across care everywhere, now fast-growing.
Global Medical Device Cybersecurity Market – By Security Type
- Introduction/Key Findings
- Network Security
- Endpoint Security
- Application Security
- Cloud Security
- Others
- Y-O-Y Growth Trend & Opportunity Analysis
Global Medical Device Cybersecurity Market – By Deployment Mode
- Introduction/Key Findings
- On-Premise
- Cloud-Based
- Hybrid
- Others
- Y-O-Y Growth Trend & Opportunity Analysis
Global Medical Device Cybersecurity Market – By Device Type
- Introduction/Key Findings
- Implantable Devices
- Wearable & Portable Devices
- Stationary Medical Devices
- Diagnostic & Monitoring Devices
- Others
- Y-O-Y Growth Trend & Opportunity Analysis
Global Medical Device Cybersecurity Market – By End User

- Introduction/Key Findings
- Hospitals & Healthcare Providers
- Medical Device Manufacturers
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Others
- Y-O-Y Growth Trend & Opportunity Analysis
Hospitals & Healthcare Providers are the largest with a 51.6% share in 2026, due to the largest number of connected devices and direct exposure to downtime. Manufacturers are 24.3% with growing secure-by-design budgets today globally across bids and upgrades this year.
Medical device manufacturers are the fastest growing, with a 13.6% CAGR by 2030 due to product lifecycle needs and update responsibility. Hospitals continue to invest steadily to ensure clinical availability and operations globally, now with risks every day there today.
Global Medical Device Cybersecurity Market– Regional Analysis
- North America
- Europe
- Asia-Pacific
- Latin America
North America leads with 38% in 2026 with established hospital systems, budgets, and regulations. Europe is next at 18% due to compliance and upgrade projects today across major hospitals, now here each day so far.
The fastest-growing region is the Asia Pacific at 14.7% CAGR to 2030 for hospital digitization and smart care. The Middle East & Africa is at 10%, with cybersecurity spending on the rise now across markets this year ahead with new hospital builds.

Latest Market News
Mar 26, 2026: Stryker has stated most of its manufacturing facilities and key production lines are back up and running following a March 11, 2026 cyberattack, and customer ordering systems have been returned to service. Stryker employs 56,000 people and operates in 61 countries, underlining the risk in the medical device industry.
Mar 17, 2026: Stryker said it had isolated the network attack, originally reported on Mar 11, 2026, and was focusing on rebuilding shipping and order systems. It again stated it operates in 61 countries and employs 56,000 people, highlighting the need for global device suppliers to be resilient.
Mar 11, 2026 Stryker stock dropped 3.6% on reports of a potential cyberattack that affected internal systems and remote Windows devices. The firm said there was no impact to patient-connected devices and continued to operate in 61 countries.
On Feb 27, 2026, UFP Technologies reported a Feb 14, 2026, cybersecurity attack impacted its billing and labeling systems, with some data confirmed to have been stolen or destroyed. Access to most systems was restored within about 13 days, it said, with ongoing investigations.
Jun 27, 2025 The FDA released final medical device cybersecurity guidance broadening Section 524B requirements to include lifecycle security, software bill of materials, and postmarket practices. This replaced the Sep 27, 2023 guidance, establishing a new set of guidelines across 2 major versions.
Jan 30, 2025 The FDA issued an alert of cybersecurity risks with Contec CMS8000 and Epsimed MN-120 patient monitors in hospitals and at home. The FDA listed the risks for 2 models of the monitors and claimed 0 reported injuries and deaths related to the vulnerability at the time.
Oct 24, 2024 The U.S. Food and Drug Administration released a white paper on how to deal with software bill of materials data normalization for medical device manufacturers. The paper addressed 1 key SBOM process for enhancing cybersecurity transparency and followed another technical paper on Oct 12, 2024.
On Oct 12, 2024, U.S. regulators published a journal article on digital certificate management for connected medical devices, which stresses the need for scalable system identity controls. This is 12 days before the Oct 24, 2024 SBOM white paper, the latest in a series of Q4 2024 policy releases.
Key Players
- Palo Alto Networks, Inc.
- Cisco Systems, Inc.
- Fortinet, Inc.
- Check Point Software Technologies Ltd.
- Trend Micro Incorporated
- CrowdStrike Holdings, Inc.
- Microsoft Corporation
- IBM Corporation
- MedCrypt, Inc.
- Claroty Ltd.
Questions buyers ask before purchasing this report
How do I know this market size is not overstated?
A credible report separates medical device cybersecurity revenue from general hospital IT security budgets. It defines what counts, what does not, and how mixed contracts are treated. It should also explain how services, software, and hardware are segmented. If the boundary is vague, totals are often inflated and hard to use for planning.
Should I prioritize hospitals or manufacturers as customers?
That depends on your route to value. Hospitals may offer faster operational pain points and urgent budgets after incidents. Manufacturers may offer larger strategic contracts tied to product lifecycle needs. A good report helps compare sales cycles, proof burdens, renewal patterns, and integration demands across both groups.
Is cloud-based deployment always the best choice?
No. Cloud can improve scale and analytics, but some environments need local control, latency protection, or stricter internal policy alignment. Many buyers land on hybrid models. The right report should show where each model fits by buyer maturity, asset mix, and compliance posture.
What signals suggest buying urgency right now?
Recent incidents, insurance scrutiny, audit deadlines, hospital expansion, fleet modernization, and merger activity often raise urgency. Delays can increase exposure and raise later remediation costs. If several signals are active at once, timing risk is higher.
What should I compare between vendors beyond features?
Look at integration speed, update reliability, support coverage, false alert rates, deployment burden, customer references, and evidence of reducing downtime. Features alone rarely predict success in clinical environments.
How useful are regional splits in this market?
Very useful when done properly. Demand varies by installed device base, healthcare digitization, procurement maturity, and regulation. A global average can hide stronger opportunities or slower markets. Regional granularity helps with sales planning and entry timing.
Can services matter more than products?
Yes. Many healthcare buyers lack deep in-house device security teams. Managed detection, advisory support, response retainers, and lifecycle services can become core spend. In some markets, services can be stickier than standalone tools.
What mistakes do first-time buyers make with this report category?
They accept broad growth claims, ignore market boundaries, underestimate deployment friction, and skip stakeholder-specific demand analysis. They also treat all connected devices as equal risk. Better reports reduce these mistakes by showing where spend is real and where assumptions fail.